Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMC 232751)

Published in J Clin Microbiol on May 01, 1997

Authors

E Garza-González1, M Guerrero-Olazarán, R Tijerina-Menchaca, J M Viader-Salvadó

Author Affiliations

1: Departamento de Bioquímica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.

Articles cited by this

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med (1992) 13.29

Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol (1991) 7.27

Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. J Clin Microbiol (1988) 6.42

Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J Clin Microbiol (1992) 3.36

High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis. J Clin Microbiol (1990) 3.27

Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography. J Clin Microbiol (1992) 3.03

High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. J Clin Microbiol (1986) 2.51

Routine application of high-performance liquid chromatography for identification of mycobacteria. J Clin Microbiol (1993) 1.92

Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models. J Clin Microbiol (1995) 1.56

Curvilinear-gradient high-performance liquid chromatography for identification of mycobacteria. J Clin Microbiol (1993) 1.24

Articles by these authors

Characterisation of Helicobacter pylori isolates from the north-eastern region of Mexico. Clin Microbiol Infect (2004) 1.18

Identification of mycobacteria by mycolic acid pattern. Arch Med Res (1998) 0.93

Drug Susceptibility of Mycobacterium tuberculosisThrough the Mycolic Acid Index. Methods Mol Med (2001) 0.86

Mg2+, Mn2+, and Co2+ stimulate Entamoeba histolytica to produce chitin-like material. J Parasitol (2001) 0.84

Mycolic acid index susceptibility method for Mycobacterium tuberculosis. J Clin Microbiol (2001) 0.84

Mg, Mn, and Co ions enhance the formation of Entamoeba histolytica cyst-like structures resistant to sodium dodecyl sulfate. Arch Med Res (2000) 0.82

Pteridine concentrations differ between insectary-reared and field-collected Anopheles albimanus mosquitoes of the same physiological age. Med Vet Entomol (2002) 0.80

Preparation of Entamoeba histolytica antigens without enzymatic inhibitors. Parasitology (2005) 0.80

Natural anthracenone subcellular distribution and effects on NADPH-cytochrome P450 reductase microsomal activity. Drug Chem Toxicol (1996) 0.78

Identification of seven chemical factors that favor high-quality Entamoeba histolytica cyst-like structure formation under axenic conditions. Arch Med Res (2000) 0.78

Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico. J Chemother (2002) 0.77

[HCV and HBV seropositivity in university students of the State of Nuevo Leòn, Mexico]. Rev Gastroenterol Mex (1997) 0.76

Systemic antiamebic antibodies induced orally in mice: detection by an ELISA test using preserved Entamoeba histolytica-antigens without enzymatic inhibitors. Arch Med Res (2000) 0.75

Bacteriostatic and bactericidal activity of rabeprazole against Helicobacter pylori. J Chemother (2004) 0.75

[Pharmacokinetic design for the preclinical phase. Application to the study of an anthracenone]. Rev Invest Clin (1994) 0.75

Detecting residual bcr-abl transcripts in chronic myeloid leukaemia patients using coupled reverse transcriptase-polymerase chain reaction with rTth DNA polymerase. Clin Lab Haematol (1998) 0.75